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Abstract
Background: Wearables for monitoring physical activity (PA) are increasingly popular. These devices are not only used by
consumers to monitor their own levels of PA but also by researchers to track the behavior of large samples. Consequently, it is
important to explore how accurately PA can be tracked via these devices.
Objectives: The aim of this study was, therefore, to investigate convergent validity of 3 Android Wear smartwatches—Polar
M600 (Polar Electro Oy, Kempele, Finland), Huawei Watch (Huawei Technologies Co, Ltd, Shenzhen, Guangdong, China),
Asus Zenwatch3 (AsusTek Computer Inc, Taipei, Taiwan)—and Fitbit Charge with an ActiGraph accelerometer for measuring
steps and moderate to vigorous physical activity (MVPA) on both a day level and 15-min level.
Methods: A free-living protocol was used in which 36 adults engaged in usual daily activities over 2 days while wearing 2
different wearables on the nondominant wrist and an ActiGraph GT3X+ accelerometer on the hip. Validity was evaluated on
both levels by comparing each wearable with the ActiGraph GT3X+ accelerometer using correlations and Bland-Altman plots
in IBM SPSS 24.0.
Results: On a day level, all devices showed strong correlations (Spearman r=.757-.892) and good agreement (interclass correlation
coefficient, ICC=.695-.885) for measuring steps, whereas moderate correlations (Spearman r=.557-.577) and low agreement
(ICC=.377-.660) for measuring MVPA. Bland-Altman revealed a systematic overestimation of the wearables for measuring steps
but a variation between over- and undercounting of MVPA. On a 15-min level, all devices showed strong correlations (Spearman
r=.752-.917) and good agreement (ICC=.792-.887) for measuring steps, whereas weak correlations (Spearman r=.116-.208) and
low agreement (ICC=.461-.577) for measuring MVPA. Bland-Altman revealed a systematic overestimation of the wearables for
steps but under- or overestimation for MVPA depending on the device.
Conclusions: In sum, all 4 consumer-level devices can be considered accurate step counters in free-living conditions. This
study, however, provides evidence of systematic bias for all devices in measurement of MVPA. The results on a 15-min level
also indicate that these devices are not sufficiently accurate to provide correct real-time feedback.
(JMIR Mhealth Uhealth 2018;6(12):e10972)   doi:10.2196/10972
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Physical inactivity is one of the major risk factors for mortality
worldwide, causing an estimated 3.2 million deaths (6%) [1].
It accounts for approximately 21% to 25% of breast and colon
cancers, 27% of type 2 diabetes, and 30% of burden because of
ischemic heart disease [2,3]. It is hence recommended to perform
a sufficient level of physical activity (PA). Physical activity is
defined as “any bodily movement produced by skeletal muscles
that require energy expenditure” [4]. PA can be classified
according to the intensity of the activity using metabolic
equivalents (METs). MET is the ratio of a person’s working
metabolic rate relative to their resting metabolic rate. One MET
is defined as the energy cost in rest and is equivalent to a caloric
consumption of 1 kcal/kg/hour. It is estimated that compared
with sitting, a person’s caloric consumption is more than 1.6
times higher and less than 3 times higher when being lightly
active (1.6-3 METs), 3 to 6 times higher when being moderately
active (3-6 METs), and more than 6 times higher when being
vigorously active (>6 METs) [5]. Adults aged 18 to 64 years
should accumulate at least 150 min of moderate-intensity aerobic
PA throughout the week or do at least 75 min of
vigorous-intensity aerobic PA throughout the week or an
equivalent combination of moderate and vigorous intensity
activity [5,6]. Another recommendation is to take at least 10,000
steps a day [7,8]. Nevertheless, 58% of the global population
does not meet either of these recommendations [9].
Increasing the level of PA in the general population has proven
notoriously difficult [10]. Scientists and practitioners have turned
to behavior change theories to better understand the process of
change and to better design interventions. Among various
behavior change techniques, self-monitoring of the PA [11,12],
has proven effective in changing PA levels. Consumer-level
devices, also referred to as wearables, are increasingly used for
the monitoring of PA [13]. They have built-in sensors to track
and quantify daily movement [14].
Various wearables exist, and we can distinguish between activity
trackers and smartwatches. Activity trackers (eg, Fitbit Flex,
Misfit Shine, Garmin Vivosmart, and Xiaomi MiBand) are
specifically built to track activity levels. Smartwatches (eg,
Apple Watch, Samsung Gear, and Huawei Watch) also track
activity levels but include other functions as well (eg, surfing
the Web, receiving and answering mails or calls, playing music,
and using the global positioning system). Furthermore,
smartwatches allow downloading of apps and can be readily
synchronized with a mobile phone. Smartwatches, therefore,
have the potential to serve as a platform for app developers.
They also have the potential to transform health care by
supporting or evaluating health in everyday living because they
(1) are familiar to most people; (2) are increasingly available
as a consumer device; (3) enable near real-time continuous
monitoring of PA and physiological measures; (4) support
tailored messaging and reminders; (5) enable communication
between patients, family members, and health care providers;
and (6) allow for in situ mini-surveys and behavior verification
based on sensor-based measure [15]. As wearables, both activity
trackers and smartwatches, are increasingly popular not only
with consumers but also with researchers [16], it is important
to determine their accuracy for measuring PA variables such as
step counts and minutes of MVPA.
Until now, only activity trackers have been scrutinized for their
validity [17-23]. These studies found that most activity trackers
(Fitbit Flex, Fitbit Zip, Fitbit One, Fitbit Charge HR, Jawbone
Up, Nike+ Fuelband SE, Misfit Shine, and Withings Pulse) are
valid for measuring steps but to a lesser extent, for measuring
MVPA. For smartwatches, the validity for measuring PA
variables (the number of steps and time spent in MVPA) has
not been investigated. This is partly because of the recent rise
in these devices: Up until 2014, about half of devices on the
market were smartwatches. In 2015 and 2016, smartwatches
represented 59.3% (143/241) of new devices on the market,
whereas fitness trackers represented 40.7% (98/241) [24].
Furthermore, there is also a need for validation of wearables
(both activity trackers and smartwatches) at a small time-scale.
To our knowledge, all validation studies using activity trackers
investigate validity on a daily level; however, validation using
a smaller time-scale (eg, 15 min) is warranted. Increasingly,
individual-focused interventions are developed that are based
on real-time feedback. Examples are Just-In-Time adaptive
interventions (JITAIs), which are the interventions that provide
the right type and amount of support at the right time by adapting
to an individual’s changing internal and contextual state. By
providing this personally tailored support, interventions can be
more effective in guiding users toward a physically active
lifestyle [25]. Due to the internal sensors, the larger screen, and
the fact that the device can be consulted constantly as they are
worn on the wrist, smartwatches have the potential to serve as
a platform for a JITAI. Notwithstanding the potential of
smartwatches for JITAIs, smartwatches should be accurate in
measuring physical active or inactive behavior during a short
time duration [25,26].
For example, when users engage in a 15-min jog, the device
has to be able to correctly categorize this behavior as 15 min of
MVPA. On the basis of this measurement, the appropriate
intervention component is to give real-time feedback to the user
that he or she is doing well without giving other suggestions
for more PA. However, when the user is not physically active
for 15 min, the device has to be able to correctly categorize this
as 15 min of physical inactivity. On the basis of this
measurement, the appropriate intervention component is to
provide real-time feedback in the form of a tailored suggestion
to the user to engage in more PA.
Objectives
The aim of this study was, therefore, to validate wearables in
an adult population on both a day level as well as a 15-min level
in free-living situations. We opted for a 15-min level because
this is the smallest time level measured by the tested
smartwatches. We opted for a validation in free living because
this increases the external validity of our findings for use of
wearables in daily life. We investigated convergent validity of
3 Android Wear smartwatches (Polar M600, Huawei Watch,
and Asus Zenwatch3) and 1 activity tracker (Fitbit Charge).
The number of steps and the time spent in MVPA measured by
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consumer-level devices was compared directly with the
measurements of an ActiGraph GT3X+ accelerometer.
Methods
Participants
In this study, 36 healthy participants (50% male; mean age 39.43
years, SD 17.77) aged between 20 and 65 years and living in
the area of Ghent (Belgium) were recruited using purposeful
sampling. The inclusion criteria were having no current physical
limitations, medical conditions, or psychiatric conditions. Before
participants were selected, they completed the International
Physical Activity Questionnaire (IPAQ, long 7d version) to
assess their current level of PA. This procedure allowed us to
have variation in the participants’ activity levels. The IPAQ was
chosen for 2 reasons. First, a self-report measure was used for
practical reasons. The self-report measurement allowed us to
assess the current PA of people by letting them fill out a 10-min
questionnaire, which makes it a very time-efficient measurement
as opposed to objective measurement. Second, earlier research
indicated that IPAQ is a reasonably reliable valid measurement
tool for measuring habitual PA [27,28]. The International
Physical Activity Questionnaire–Long Form (IPAQ-LF, last 7
days) asks participants to report the frequency and duration of
activities in the last 7 days. Activities were classified into the
domains of occupation, transportation, household, and leisure
for each category of walking, moderate-intensity PA (MPA),
and vigorous-intensity PA (VPA). Weekly and daily minutes
of total PA, MPA, and VPA were computed.
On the basis of this assessment, we included 18 participants
(50% male) who met the guideline of 30-min MVPA per day
and 18 participants (50% male) who did not meet this guideline.
All participants read and signed an informed consent form. The
study protocol was approved by the ethics committee of the
University hospital of Ghent (B670201731732).
Instruments
Convergent Measure
The ActiGraph GT3X+ (Actigraph, Pensicola, FL, USA), a
triaxial accelerometer was used as reference or convergent
measure. The ActiGraph GT3X+ has been found to be reliable
and valid. The GT3X+ is valid for measuring step counts
compared with direct observation by trained observers [29-31]
and for MVPA compared with indirect calorimetry [32,33].
Accelerometer data were initialized, downloaded, and processed
by using ActiLife version 5.5.5-software (ActiGraph, Fort
Walton Beach, FL, USA). The Freedson Adult (1998) cut-points
were used to categorize PA measured by the ActiGraph
accelerometer (sedentary activity=0-99 counts/min, light
activity=100-1951 counts/min, moderate activity=1952-5723
counts/min, and vigorous activity ≥5724 counts/min) [32]. A
15-s epoch was used when downloading the data.
Wearables
We tested 4 wearables: Fitbit Charge, Polar M600, Huawei
Watch, and Asus Zenwatch 3. Fitbits are one of the most popular
activity trackers on the market. Smartwatches from Polar,
Huawei, and Asus were selected because they use the Android
Wear platform that has a significant market share (18% during
Quarter 1 2017) and provides easy opportunities to program
smartwatches and develop apps [34]. Polar M600, Huawei
Watch, and Asus Zenwatch were selected because of their
potential for electronic health interventions at the time of data
collection (beginning of 2017). All 4 devices measure steps and
a specific variable that quantifies the degree of PA. For the
Fitbit, we used the variable active minutes, which is divided
into light active, fairly active, and very active minutes. To
approach the MVPA variable, fairly and very active minutes
were summed. For the Android Wear smartwatches, we used
the variable active time, which is calculated by summing the
time spent on various activities (walking, running, and biking)
that are all covered by the definition of MVPA (>3.0 MET) [1].
As all the devices set a goal of 30-min PA per day (similar to
the MVPA recommendations for adults), we assumed that the
measured variable corresponded to MVPA as measured by the
ActiGraph. However, specific information regarding intensity
cut-points is not publicly available. All Fitbit data were exported
in an XLS (Microsoft Excel) format using the Fitbit Dashboard
Web app. Every minute was categorized as sedentary, lightly
active, fairly active, or very active. Afterward, the data per
minute were converted to data per 15 min. Data from the
Android Wear smartwatches were exported in a CSV
(comma-separated values) format from Google Fit using Google
Take Out. Every 15 min, it was shown how many seconds were
spent on various activities (walking, running, biking, and tilting)
Free-Living Protocol
As it was neither feasible nor comfortable to wear 4 wearables
at the same time; participants were instructed to simultaneously
wear 2 of the devices and the ActiGraph accelerometer for 2
consecutive days and then the other 2 wearables and the
accelerometer for another 2 consecutive days. Between these 2
periods of 2 days, there was always a gap of 1 day on which
devices were transferred from one participant to another. The
devices were worn during all waking hours, except during
water-based activities. All participants wore all 4 different
wearables. All possible combinations of 2 wearables (a total of
6) were randomly assigned to the participants. Each combination
was tested for 24 days in total, and each device was tested for
72 days. The ActiGraph GT3X+ was fitted to the right side of
the participants’ waist, and the wearables were placed on the
nondominant wrist. Furthermore, participants were instructed
to keep a short diary in which they wrote down when they put
on the devices and when and why they took them off.
Statistical Analysis
Only days with valid data of the ActiGraph were included in
the analysis. A valid day was defined as a 24-hour period in
which at least 10 hours of data wear time was recorded. Nonwear
time was analyzed as a run of zero counts lasting more than 60
min [35,36]. Analyses were performed using IBM SPSS
Statistics version 24.0. All analyses were performed on a day
level as well as a 15-min level. First, the correlation between
the wearables and the ActiGraph accelerometer for measuring
steps and MVPA was examined by calculating the Spearman r
and ICC (absolute agreement, 2-way random, single measures,
and 95% CI). Both analyses were conducted to take into account
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the possible systematic difference between the measurements,
which is taken into account by the ICC, but not by the Spearman
correlation. The following cut-off values were used to interpret
the Spearman correlation: r<.20=very weak; .20 to .39=weak;
.40 to .59=moderate; .60 to .79=strong; and .80 to 1.0=very
strong [37]. The cut-off values to interpret the ICC were
<.60=low; .60 to .75=moderate; .75 to .90=good; and
>.90=excellent [38]. Second, to examine the level of agreement
between the wearables and the convergent measure,




Participants’ characteristics are presented in Table 1. All 36
participants wore the devices as planned. Some data were lost
because of device malfunction (2 days MVPA or steps for Asus)
and participant error such as not charging the device (4 days
MVPA or steps for Asus, Polar, Fitbit, and Huawei). No data
were lost from the ActiGraph GT3X+ accelerometers.
Validation at a Day Level
In Table 2, the mean steps and mean minutes of MVPA (SD)
per day are presented for all wearables and ActiGraph
accelerometer. Moreover the statistical significance (P value)
of the difference between the ActiGraph accelerometer and the
wearables is presented. This table shows that every wearable
overestimated the number of steps per day (not significant for
Asus). For MVPA, Huawei, Asus, and Fitbit underestimated,
whereas Polar overestimated the number of minutes of MVPA
(not significant for Fitbit).







aBased on the International Physical Activity Questionnaire data.
bBMI: body mass index.
cMVPA: moderate to vigorous physical activity.
Table 2. Mean steps and minutes of moderate to vigorous physical activity per day measured by Huawei, Asus, Polar, and Fitbit and the corresponding
ActiGraph measurements and statistical significance (P value) of the difference between the ActiGraph accelerometer and the wearables.
P valueActiGraph accelerometer, mean (SD)/dayWearable, mean (SD)/dayVariable
Huawei
.027148 (3761)8625 (4514)Steps
.0736.97 (27.63)27.24 (31.59)MVPAa (min)
Asus
.427082 (4148)7662 (4380)Steps
<.00139.53 (36.33)27.14 (33.18)MVPA (min)
Polar
<.0017234 (4076)10,864 (7517)Steps
.0336.51 (28.31)59.77 (62.94)MVPA (min)
Fitbit
.0047459 (3661)9127 (5381)Steps
.3941.98 (34.40)35.47 (49.18)MVPA (min)
aMVPA: moderate to vigorous physical activity.
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Table 3. Correlation coefficients, intraclass correlation coefficients, and 95% CI of the measurements at a day level.













aICC: interclass correlation coefficient
bP<.001.
cMVPA: moderate to vigorous physical activity.
Correlations
For measuring steps on a day level, all wearables showed strong
to very strong correlations based on the Spearman r and
moderate to good agreement based on the ICC. Correlations
between the MVPA levels from the wearables and the MVPA
levels from the ActiGraph accelerometer were moderate based
on the Spearman r. Agreements for MVPA between the
wearables and the ActiGraph accelerometer were low. The
correlation coefficients, ICC values, and associated 95% CI are
shown in Table 3. The correlations are also illustrated in Figure
1. This figure shows that the scatter of the points around the
line, reflecting the perfect agreement between measurements is
larger for measuring MVPA than for measuring steps.
Level of Agreement
Bland-Altman plots indicated the differences between the
ActiGraph accelerometer and the wearables (y-axis) against the
average number of steps or number of minutes of MVPA of the
2 devices (x-axis). Mean differences with the ActiGraph
accelerometer and the limits of agreement for each wearable
are presented in Figures 2 and 3. A positive value of the mean
difference indicates an underestimation of the wearable
compared with the golden standard, and a negative value
indicates an overestimation. The systematic differences (mean
differences) and the range between the upper and lower limits
of agreement are important to make a statement about the
validity of these wearables. The broader the range between the
lower and the upper limit, the less accurate the measurements
are. All wearables showed broad limits of agreement. For
measuring steps, the plots (presented in Figure 2) showed the
narrowest limits for Huawei (7759 steps) and the broadest limits
for Polar (18,379 steps). The Bland-Altman plots for measuring
MVPA are presented in Figure 3. For measuring MVPA, the
narrowest limits were found for Fitbit (94 min), and the broadest
limits were found for Polar (212 min).
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Figure 1. Correlations between the activity estimates per day from the wearables and the ActiGraph. Spearman r values and intraclass correlation
coefficient values denote the correlation for measuring moderate-to-vigorous physical activity or steps between the wearable and the ActiGraph. a)
P<.001. MVPA: moderate to vigorous physical activity; ICC: intraclass correlation coefficient.
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Figure 2. Bland-Altman plots of the wearables. The middle line shows the mean difference (Positive values indicate an underestimation of the wearable
and negative values indicate an overestimation) between the measurements of steps of the wearables and the ActiGraph, and the dashed lines indicate
the limits of agreement (1.96 × SD of the difference scores).
Validation at a 15-Minute Level
In Table 4, the mean steps per 15 min and mean minutes of
MVPA per 15 min are presented for all devices. Moreover, the
statistical significance (P value) of the difference between the
measurements of the ActiGraph accelerometer and the wearables
is presented. The results are displayed for (1) all 15-min time
periods (including those with no MVPA) and (2) only the 15-min
time periods in which MVPA was displayed with and without
data revealing no MVPA. We opted to also present the latter to
avoid distortion of the results. As users did not perform any PA
during most periods of the day, a good agreement would be
easy to obtain because of the many zero measurements by both
measuring devices (wearable and ActiGraph accelerometer). In
addition, this would reflect the validity of measuring physical
inactivity rather than validity of measuring PA. Table 4 shows
that every wearable device overestimated the number of steps
per 15 min (all significant). For MVPA, Asus underestimated,
whereas Huawei, Polar, and Fitbit overestimated the number of
minutes of MVPA (not significant for Asus).
Correlation
All devices showed strong to very strong correlation based on
the Spearman r and good agreement based on the ICC for
measuring steps. For measuring MVPA (only including the data
without zeros), correlations between readings from the wearables
and the ActiGraph accelerometer were very weak to weak based
on the Spearman r. Agreement between all the wearables and
the ActiGraph accelerometer was low. The correlation
coefficients, ICC values, and associated 95% CIs are shown in
Table 5. The correlations are also illustrated in Figure 4. This
figure revealed a systematic difference between the
measurements of the wearables and the ActiGraph. The
systematic difference increased as the number of steps or number
of minutes MVPA increased. For example, an overestimation
of 20% results in a difference of 200 steps on a day with 1000
steps. On a day, however, with 8000 steps, the difference
between the measurements is 1600 steps. This is also evident
from the Bland-Altman plot (Figure 5).
Level of Agreement
Mean differences with the ActiGraph accelerometer and the
limits of agreement for each wearable device for measuring
steps and MVPA are presented in Figure 5. For measuring steps,
Huawei (503 steps) had the narrowest limits and Polar (770
steps) had the broadest limits. For MVPA, Asus (13.14 min)
had the narrowest limits, and Fitbit (17.26 min) had the broadest
limits.
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Figure 3. Bland-Altman plots of the consumer-level devices. The middle line shows the mean difference (Positive values indicate an underestimation
of the consumer-level device and negative values indicate an overestimation) between the measurements of moderate-to-vigorous physical activity of
the device and the ActiGraph, and the dashed lines indicate the limits of agreement (1.96 × SD of the difference scores). MVPA: moderate to vigorous
physical activity.
Table 4. Mean steps and minutes of moderate to vigorous physical activity per 15 min measured by Huawei, Asus, Polar, and Fitbit and the corresponding
ActiGraph measurements and statistical significance (P value) of the difference between the ActiGraph accelerometer and the wearables.
P valueActiGraph accelerometer, mean (SD)/15 minWearable, mean (SD)/15 minVariable
Huawei
<.001148 (236)184 (263)Steps
.112.53 (3.19)2.91 (4.68)MVPAa with zeros deleted (min)
<.0010.54 (1.79)0.86 (3.06)MVPA (min)
Asus
.04147 (241)166 (228)Steps
.762.50 (3.67)2.44 (3.62)MVPA with zeros deleted (min)
.760.61 (2.12)0.60 (2.07)MVPA (min)
Polar
<.001145 (241)231 (358)Steps
<.0011.62 (2.86)3.75 (4.40)MVPA with zeros deleted (min)
<.0010.52 (1.78)1.20 (3.03)MVPA (min)
Fitbit
<.001151 (247)192 (304)Steps
.0032.86 (3.82)3.59 (5.28)MVPA with zeros deleted (min)
.010.62 (2.13)0.78 (2.86)MVPA (min)
aMVPA: moderate to vigorous physical activity.
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Table 5. Correlation coefficients, intraclass correlation coefficients, and 95% CIs of measurements at a 15-min level.













aICC: interclass correlation coefficient
bP<.001.
cMVPA: moderate to vigorous physical activity.
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Figure 4. Correlations between the activity estimates per 15 min from the wearables and the ActiGraph GT3X+, Spearman r values, and intraclass
correlation coefficient values that denote the correlation for measuring moderate to vigorous physical activity or steps between the wearables and the
ActiGraph. a) P<.001. ICC: intraclass correlation coefficient; MVPA: moderate to vigorous physical activity.
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Figure 5. Bland-Altman plots of the wearables. The middle line shows the mean difference (positive values indicate an underestimation of the wearable
and negative values indicate an overestimation) between the wearables and the ActiGraph, and the dashed lines indicate the limits of agreement (1.96
× SD of the difference scores). MVPA: moderate to vigorous physical activity.
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This study investigated the validity of 4 wearables (3
smartwatches and 1 activity tracker) for measuring steps and
MVPA in naturalistic situations. Validity was investigated
separately for a day level and a 15-min level. The ActiGraph
GT3X+ accelerometer was used as a convergent measure. The
results can be readily summarized.
First, all 4 wearables showed good validity for measuring steps
on a day level and a 15-min level. Nevertheless, all devices
overestimated the number of steps. Second, for estimating
MVPA, our study results demonstrated systematic bias for all
wearables, both on a day level and a 15-min level, suggesting
the validity is moderate to low for MVPA.
Although we cannot compare the overestimations of the steps
per day for the smartwatches with previous studies, an
overestimation for Fitbit has been reported before [18,35,39].
These studies showed that Fitbit overestimated steps on average
by about 4% to 13% per day (step difference between wearable
and Actigraph/steps measurement of the ActiGraph), which is
a smaller overestimation than what we found. The
overestimation for Fitbit (on average 1709/9126 steps, 18.72%),
Huawei (on average 1477/8626 steps, 17.12%), and Polar (on
average 3630/10,854 steps, 33.44%) was substantially larger.
The overestimation on a day level was the smallest for Asus
(on average 652 on 7662 steps; 8.50%). Moreover, on a 15-min
level, all 4 devices overestimated the amount of steps: Huawei
with on average 19.0% (35/184 steps), Asus with on average
10.8% (18/166 steps), Polar with 37.2% (86/231 steps), and
Fitbit with 21.2% (41/193 steps). When looking at the limits of
agreement on both levels, Polar shows the broadest limits,
whereas Huawei shows the smallest limits. From this, it can be
concluded that Polar is the least accurate device for measuring
steps and that, despite the smallest mean difference being that
of Asus, Huawei is the most accurate device for measuring steps.
There are several reasons that may account for the systematic
overestimation. First, the overestimation may also be explained
by the different wear location of the devices. The ActiGraph
GT3X+ is worn on the hip, whereas the wearables are worn on
the wrist. This by itself could result in different measurements.
Previous research concluded that wrist attachment devices
detected consistently fewer counted steps than the waist
attachment devices at most treadmill speeds during laboratory
testing. In contrast, wrist attachment devices detected a higher
average step count than the waist attachment devices under
free-living conditions [40]. Second, the overestimation may
also be explained by the algorithms used to convert raw activity
data from the different sensors in the watches into steps.
Companies may use a lower threshold for steps than the
threshold for the ActiGraph accelerometer algorithm. In line
with this hypothesis, the systematic error increased as the
number of steps increased.
All devices displayed information on how much time per day
was spent in PA of at least moderate intensity. In contrast to
measuring steps, wearables showed only moderate validity for
measuring MVPA relative to the ActiGraph GT3X+
accelerometer on a day level and even low validity on a 15-min
level. Whether MVPA was overestimated or underestimated
varied depending on the device type and the time level. On a
day level, Fitbit, Huawei, and Asus underestimated MVPA with
an average of 30% (10/35 min per day), 16% (9/57 min per
day), and 36% (12/33 min per day), respectively, whereas Polar
overestimated MVPA with 33% (23/70 min per day). When
looking at the limits of agreement on a day level, Fitbit shows
the narrowest limits, whereas Polar shows the broadest limits.
Moreover, Huawei shows rather narrow limits, making it, in
combination with the small mean difference, the most accurate
for measuring MVPA on a day level. Polar, however, is the least
accurate. On a 15-min level, Fitbit, Huawei, and Polar
overestimated MVPA with 20% (0.72/3.60 min), 13% (0.38/2.91
min), and 57% (2.13/3.75 min), respectively, whereas Asus
underestimated MVPA with 2% (0.06/2.44 min). Asus also
showed the narrowest limits of agreement, meaning it is the
most accurate wearable device for measuring MVPA on a
15-min level. The results of Fitbit Charge on a day level are in
line with the findings of a validation study of Fitbit Flex in
naturalistic settings in which an underestimation of 36% time
spent on MVPA per day was found [21]. Other studies in
naturalistic settings found an overestimation of the MVPA
measurements by Fitbit on a day level with 77% to 153% per
day [19,41]; however, in these studies, Fitbit was worn on the
hip. The difference between the findings of these previous
studies and this study can, therefore, be explained by the
placement of the wearable. Ferguson et al and Reid et al
investigated the validity of Fitbit One, Fitbit Zip, and Fitbit
Flex. All these wearables are worn on the hip.
A possible explanation for the moderate to low validity found
in our study could be that the PA variables measured by the
devices were not explicitly identified as MVPA. However,
because all devices had set a goal of 30 min PA per day (similar
to the MVPA recommendations for adults), we assumed that
the measured variable corresponded to MVPA as measured by
the ActiGraph accelerometer. Nevertheless, specific information
regarding intensity cut-points was not provided and publicly
available from these 4 wearables. An earlier study showed that
using different intensity cut-points in accelerometers resulted
in different MVPA levels [42], suggesting that it is difficult to
compare accelerometer MVPA measurements when intensity
cut-points vary. This could be the case in this study, which
makes it difficult to compare the Actigraph accelerometer
MVPA measurements with the wearable MVPA measurements
[43]. However, our results showed large inconsistent
underestimations and overestimations between and within
participants, which cannot only be attributed to the lack of
definitional similarity of the measured variable. Therefore, the
discrepancies here may be a result of both definitional and
measurement problems (eg, sensitivity algorithm). These
findings are in line with previous studies that have expressed
concerns that such devices might not be able to provide adequate
information to guide exercise intensity or detect MVPA [17].
The inclusion of 4 popular devices enables to draw conclusions
on the validity of these 4 smartwatches and not only on a
singular device. Moreover, to the best of our knowledge, this
was the first study to explore validity of smartwatches to
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measure steps and MVPA. The key strength of this study is the
validation of the wearables on a 15-min level to investigate the
potential of the devices to correctly situate physically active
behavior over time to provide exact real-time feedback on PA
behavior. Despite the clear results of this study, it is important
to see them in the context of the purpose of the devices. The
main purpose of these devices is to motivate the user to move
more in everyday life, suggesting that 100% accurate
measurements might not be needed. Modest accuracy can be
good enough for this purpose [44]. Furthermore, this study has
some other limitations. First, the choice of a 15-min level is
arbitrary. It was the smallest data collection window in the
Android Wear smartwatches. Ideally, validation on a smaller
time-level, such as 1 or 5 min, should be performed to be able
to better estimate the potential for providing real-time feedback.
However, we can, based on the 15-min timescale, assume that
these wearables will logically also not be accurately measuring
MVPA on a smaller time-scale (eg, 10 min, 5 min, 1 min, and
30 s). Second, we used the ActiGraph accelerometer as
convergent measure and not as a criterion measure, meaning it
may not be considered the true golden standard. Although earlier
studies showed good validity of the ActiGraph GT3X+ for
measuring MVPA compared with indirect calorimetry, the main
limitation for both uniaxial and triaxial accelerometers is the
inability to accurately assess the movement associated with
nonambulatory activity, such as cycling, especially with
hip-worn devices [45]. For measuring steps, the golden standard
is direct observation. For measuring MVPA, which is a complex
and multifaceted construct, there is currently no consensus
[46,47]. As by definition, PA leads to energy expenditure; the
doubly labeled water (DLW) method, which assesses total
energy expenditure over longer periods of time, is the golden
standard to assess physical activities in laboratory settings
[47,48]. However, because of feasibility, direct observation and
DLW are impossible in free-living conditions. The ActiGraph
was, therefore, by approximation, the best available golden
standard. Third, the sample size was small but comparable with
previous validation studies [19-21,38,41,49]. Fourth, the
development of new wearables that appear on the market is
going fast. Therefore, the need for further validation in
naturalistic settings remains. Obviously, it is not possible to
validate each single new device coming onto the market.
However, we must always remain critical of measurements of
PA by new devices, and research must continue to invest
resources and time in this type of research, especially when new
devices also have potential to be used within research. In this
respect, it may be very useful in the future when manufacturers
provide more insight into the cut-points and algorithms that
were used to translate the raw data into useful information (such
as steps and minutes of MVPA).
Conclusions
Generally, it can be concluded that all 4 consumer-level devices
(Huawei Watch, Polar M600, Asus ZenWatch2, and Fitbit
Charge) are valid devices to estimate the amount of steps in
naturalistic situations on both a day level and 15-min level.
Nevertheless, for estimating MVPA, our study reveals
systematic bias for all devices, both on a day level and a 15-min
level, suggesting the validity is moderate to low for MVPA.
This suggests that these wearables cannot replace the current
generation of research-based accelerometers such as the
ActiGraph GT3X+ to assess MVPA. The MVPA results on a
15-min level also indicate that these devices are not accurate in
giving feedback on how many minutes the user performed
MVPA in the past 15 min. Although we were not able to
investigate validity on a smaller time-scale, we can, based on
the 15-min time-scale, assume that these wearables will not be
accurate in measuring MVPA on a smaller time-scale as well
(eg, 10 min, 5 min, 1 min, 30 s). Consequently, these wearables
cannot be considered to have the potential to provide exact
real-time feedback on minutes MVPA. Therefore, we conclude
that these wearables cannot be used to inform the design of a
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